{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:09:14Z","timestamp":1788880154021,"version":"build-2803163510"},"posted":{"date-parts":[[2023,11,30]]},"group-title":"Gastroenterology","reference-count":71,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,11,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>BACKGROUND &amp; AIMS<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 25% of the population and currently has no effective treatments. Plasma proteins with causal evidence may represent promising drug targets. We aimed to identify plasma proteins in the causal pathway of MASLD and explore their interaction with obesity.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We analysed 2,941 plasma proteins in 43,978 European participants from UK Biobank. We performed genome-wide association study (GWAS) for all MASLD-associated proteins and created the largest MASLD GWAS (109,885 cases\/1,014,923 controls). We performed Mendelian Randomization (MR) and integrated proteins and their encoding genes in MASLD ranges to identify candidate causal proteins. We then validated them through independent replication, exome sequencing, liver imaging, bulk and single-cell gene expression, liver biopsies, pathway, and phenome-wide data. We explored the role of obesity by MR and multivariable MR across proteins, body mass index, and MASLD.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We found 929 proteins associated with MASLD, reported five novel genetic loci associated with MASLD, and identified 17 candidate MASLD protein targets. We identified four novel targets for MASLD (CD33, GRHPR, HMOX2, and SCG3), provided protein evidence supporting roles of AHCY, FCGR2B, ORM1, and RBKS in MASLD, and validated nine previously known targets. We found that CD33, FCGR2B, ORM1, RBKS, and SCG3 mediated the association of obesity and MASLD, and HMOX2, ORM1, and RBKS had effect on MASLD independent of obesity.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>This study identified new protein targets in the causal pathway of MASLD, providing new insights into the multi-omics architecture and pathophysiology of MASLD. These findings advise further therapeutic interventions for MASLD.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.11.30.23299247","type":"posted-content","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T16:15:11Z","timestamp":1701360911000},"source":"Crossref","is-referenced-by-count":13,"title":["Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targets"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-3042","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sile","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar Augusto Prada","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-2040","authenticated-orcid":false,"given":"Tom G","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Traylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall J","family":"Dempster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mbasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Monfeuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-5714","authenticated-orcid":false,"given":"Marijana","family":"Vujkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6205-9994","authenticated-orcid":false,"given":"Benjamin F.","family":"Voight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-9364","authenticated-orcid":false,"given":"Kyong-Mi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VA Million Veteran Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy F","family":"Cobbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy W","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M","family":"van Duijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M M","family":"Howson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2023120206200432000_2023.11.30.23299247v1.1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","year":"2023","journal-title":"J. Hepatol"},{"key":"2023120206200432000_2023.11.30.23299247v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015"},{"key":"2023120206200432000_2023.11.30.23299247v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.230"},{"key":"2023120206200432000_2023.11.30.23299247v1.4","unstructured":"UK Biobank. Available at: https:\/\/biobank.ndph.ox.ac.uk\/showcase\/. Accessed Jun 7, 2022."},{"key":"2023120206200432000_2023.11.30.23299247v1.5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","year":"2005","journal-title":"Hepatol. Baltim. Md"},{"key":"2023120206200432000_2023.11.30.23299247v1.6","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/oby.22210","article-title":"Body Composition Profiling in the UK Biobank Imaging Study","volume":"26","year":"2018","journal-title":"Obes. Silver Spring Md"},{"key":"2023120206200432000_2023.11.30.23299247v1.7","doi-asserted-by":"crossref","first-page":"e000572","DOI":"10.1136\/bmjgast-2020-000572","article-title":"Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM","volume":"8","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"2023120206200432000_2023.11.30.23299247v1.8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep4.1805","article-title":"Genome-Wide Association Study of NAFLD Using Electronic Health Records","volume":"6","year":"2022","journal-title":"Hepatol. Commun"},{"key":"2023120206200432000_2023.11.30.23299247v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0579-z"},{"key":"2023120206200432000_2023.11.30.23299247v1.10","unstructured":"UK Biobank Genotyping of 500,000 UK Biobank participants. version 2.0. https:\/\/biobank.ndph.ox.ac.uk\/showcase\/showcase\/docs\/ukb_dna_processing.pdf (2017). 20 Jun, 2022."},{"key":"2023120206200432000_2023.11.30.23299247v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-021-04103-Z"},{"key":"2023120206200432000_2023.11.30.23299247v1.12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","year":"2023","journal-title":"Nature"},{"key":"2023120206200432000_2023.11.30.23299247v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.hdy.6800717"},{"key":"2023120206200432000_2023.11.30.23299247v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1074"},{"key":"2023120206200432000_2023.11.30.23299247v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/S41588-021-00870-7"},{"key":"2023120206200432000_2023.11.30.23299247v1.16","doi-asserted-by":"crossref","first-page":"100437","DOI":"10.1016\/j.xcrm.2021.100437","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","year":"2021","journal-title":"Cell Rep. Med"},{"key":"2023120206200432000_2023.11.30.23299247v1.17","unstructured":"Finngen Freeze R9; Available at: https:\/\/www.finngen.fi\/en\/access_results; Accessed Sep 22, 2022."},{"key":"2023120206200432000_2023.11.30.23299247v1.18","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.26.20248491"},{"key":"2023120206200432000_2023.11.30.23299247v1.19","first-page":"2190","article-title":"METAL: fast and efficient meta-analysis of genomewide association scans","volume":"26","year":"2010","journal-title":"Bioinforma. Oxf. Engl"},{"key":"2023120206200432000_2023.11.30.23299247v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00978-w"},{"key":"2023120206200432000_2023.11.30.23299247v1.21","doi-asserted-by":"crossref","first-page":"e65554","DOI":"10.7554\/eLife.65554","article-title":"Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning","volume":"10","year":"2021","journal-title":"eLife"},{"key":"2023120206200432000_2023.11.30.23299247v1.22","unstructured":"GTEx Consortium. Genotype-Tissue Expression (GTEx). Available at https:\/\/www.gtexportal.org\/, Accessed Jul 7, 2022."},{"key":"2023120206200432000_2023.11.30.23299247v1.23","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy271"},{"key":"2023120206200432000_2023.11.30.23299247v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.04.007"},{"key":"2023120206200432000_2023.11.30.23299247v1.25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408"},{"key":"2023120206200432000_2023.11.30.23299247v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7"},{"key":"2023120206200432000_2023.11.30.23299247v1.27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41467-019-14156-4","article-title":"A robust and efficient method for Mendelian randomization with hundreds of genetic variants","volume":"11","year":"2020","journal-title":"Nat. Commun"},{"key":"2023120206200432000_2023.11.30.23299247v1.28","doi-asserted-by":"crossref","first-page":"e1009575","DOI":"10.1371\/journal.pgen.1009575","article-title":"Causal inference for heritable phenotypic risk factors using heterogeneous genetic instruments","volume":"17","year":"2021","journal-title":"PLoS Genet"},{"key":"2023120206200432000_2023.11.30.23299247v1.29","unstructured":"Pan-UKB team. Pan-UKB 2020. Available at: https:\/\/pan.ukbb.broadinstitute.org. Accessed July 7, 2023."},{"key":"2023120206200432000_2023.11.30.23299247v1.30","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-020-20885-8","article-title":"A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits","volume":"12","year":"2021","journal-title":"Nat. Commun"},{"key":"2023120206200432000_2023.11.30.23299247v1.31","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.09.21252822"},{"key":"2023120206200432000_2023.11.30.23299247v1.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01261-5"},{"key":"2023120206200432000_2023.11.30.23299247v1.33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s44161-021-00009-1","article-title":"A mechanistic framework for cardiometabolic and coronary artery diseases","volume":"1","year":"2022","journal-title":"Nat. Cardiovasc. Res"},{"key":"2023120206200432000_2023.11.30.23299247v1.34","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba4448"},{"key":"2023120206200432000_2023.11.30.23299247v1.35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2023120206200432000_2023.11.30.23299247v1.36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13073-022-01055-5","article-title":"Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival","volume":"14","year":"2022","journal-title":"Genome Med"},{"key":"2023120206200432000_2023.11.30.23299247v1.37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep4.1854","article-title":"Single-Cell, Single-Nucleus, and Spatial RNA Sequencing of the Human Liver Identifies Cholangiocyte and Mesenchymal Heterogeneity","volume":"6","year":"2022","journal-title":"Hepatol. Commun"},{"key":"2023120206200432000_2023.11.30.23299247v1.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1631-3"},{"key":"2023120206200432000_2023.11.30.23299247v1.39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add3949"},{"key":"2023120206200432000_2023.11.30.23299247v1.40","doi-asserted-by":"crossref","first-page":"eadc9653","DOI":"10.1126\/scitranslmed.adc9653","article-title":"Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis","volume":"15","year":"2023","journal-title":"Sci. Transl. Med"},{"key":"2023120206200432000_2023.11.30.23299247v1.41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","year":"2022","journal-title":"Cell"},{"key":"2023120206200432000_2023.11.30.23299247v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1373-2"},{"key":"2023120206200432000_2023.11.30.23299247v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6"},{"key":"2023120206200432000_2023.11.30.23299247v1.44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw943"},{"key":"2023120206200432000_2023.11.30.23299247v1.45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080747"},{"key":"2023120206200432000_2023.11.30.23299247v1.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01078-z"},{"key":"2023120206200432000_2023.11.30.23299247v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01261-5"},{"key":"2023120206200432000_2023.11.30.23299247v1.48","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1046"},{"key":"2023120206200432000_2023.11.30.23299247v1.49","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab953"},{"key":"2023120206200432000_2023.11.30.23299247v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01199-5"},{"key":"2023120206200432000_2023.11.30.23299247v1.51","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.3390\/ijms23169296","article-title":"Hepatic PEMT Expression Decreases with Increasing NAFLD Severity","volume":"23","year":"2022","journal-title":"Int. J. Mol. Sci"},{"key":"2023120206200432000_2023.11.30.23299247v1.52","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.81474"},{"key":"2023120206200432000_2023.11.30.23299247v1.53","unstructured":"GWAS Catalog EMBL-EBI. Available at: https:\/\/www.ebi.ac.uk\/gwas\/. Accessed Sep 22, 2023."},{"key":"2023120206200432000_2023.11.30.23299247v1.54","doi-asserted-by":"crossref","first-page":"109526","DOI":"10.1016\/j.celrep.2021.109526","article-title":"Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria","volume":"36","year":"2021","journal-title":"Cell Rep"},{"key":"2023120206200432000_2023.11.30.23299247v1.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.040"},{"key":"2023120206200432000_2023.11.30.23299247v1.56","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/jcm8091436","article-title":"Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels","volume":"8","year":"2019","journal-title":"J. Clin. Med"},{"key":"2023120206200432000_2023.11.30.23299247v1.57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35553-2"},{"key":"2023120206200432000_2023.11.30.23299247v1.58","doi-asserted-by":"crossref","first-page":"112697","DOI":"10.1016\/j.celrep.2023.112697","article-title":"Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1\/2-PPAR\u03b3-Cd36 pathway","volume":"42","year":"2023","journal-title":"Cell Rep"},{"key":"2023120206200432000_2023.11.30.23299247v1.59","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s42255-022-00627-4","article-title":"Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis","volume":"4","year":"2022","journal-title":"Nat. Metab"},{"key":"2023120206200432000_2023.11.30.23299247v1.60","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.07.047"},{"key":"2023120206200432000_2023.11.30.23299247v1.61","doi-asserted-by":"crossref","first-page":"e0211543","DOI":"10.1371\/journal.pone.0211543","article-title":"Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease","volume":"14","year":"2019","journal-title":"PloS One"},{"key":"2023120206200432000_2023.11.30.23299247v1.62","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.3390\/ijms19102932","article-title":"Fc Gamma Receptor IIb Expressed in Hepatocytes Promotes Lipid Accumulation and Gluconeogenesis","volume":"19","year":"2018","journal-title":"Int. J. Mol. Sci"},{"key":"2023120206200432000_2023.11.30.23299247v1.63","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2017.3853"},{"key":"2023120206200432000_2023.11.30.23299247v1.64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12944-016-0367-4","article-title":"Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study","volume":"15","year":"2016","journal-title":"Lipids Health Dis"},{"key":"2023120206200432000_2023.11.30.23299247v1.65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001324"},{"key":"2023120206200432000_2023.11.30.23299247v1.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.005"},{"key":"2023120206200432000_2023.11.30.23299247v1.67","doi-asserted-by":"crossref","first-page":"e0220659","DOI":"10.1371\/journal.pone.0220659","article-title":"Plasma ApoE elevations are associated with NAFLD: The PREVEND Study","volume":"14","year":"2019","journal-title":"PloS One"},{"key":"2023120206200432000_2023.11.30.23299247v1.68","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","year":"2009","journal-title":"Hepatol. Baltim. Md"},{"key":"2023120206200432000_2023.11.30.23299247v1.69","doi-asserted-by":"crossref","first-page":"837","DOI":"10.5604\/16652681.1171767","article-title":"Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease","volume":"14","year":"2015","journal-title":"Ann. Hepatol"},{"key":"2023120206200432000_2023.11.30.23299247v1.70","doi-asserted-by":"crossref","first-page":"e0237430","DOI":"10.1371\/journal.pone.0237430","article-title":"Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program","volume":"15","year":"2020","journal-title":"PloS One"},{"key":"2023120206200432000_2023.11.30.23299247v1.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2022.04.001"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.11.30.23299247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:45:53Z","timestamp":1768506353000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.11.30.23299247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1101\/2023.11.30.23299247","relation":{},"subject":[],"published":{"date-parts":[[2023,11,30]]},"subtype":"preprint"}}